Serum Levels of Carcinoembryonic Antigen in Patients with Type 2 Diabetes
Authors:
- Ayman A. ZayedAZAyman A. Zayed
- Abdallah M. BeanoABAbdallah M. Beano
- Farah N. AmerFAFarah N. Amer
- Jumana M. MaslamaniJMJumana M. Maslamani
- Mohammad A. ZmailiMZMohammad A. Zmaili
- Talha H. Al-KhudaryTATalha H. Al-Khudary
- Munther S. MomaniMMMunther S. Momani
- Al-Motassem F. YousefAYAl-Motassem F. Yousef
- 1 November 2016
- journal article
- Published by Elsevier in Endocrine Practice
- Vol. 22 (11) , 1310-1318
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Serum levels of cancer biomarkers in diabetic and non-diabetic proteinuric patients: a preliminary studyClinical Chemistry and Laboratory Medicine (CCLM), 2012
- Exocrine Pancreatic Insufficiency in Diabetes Mellitus: A Complication of Diabetic Neuropathy or a Different Type of Diabetes?Experimental Diabetes Research, 2011
- Diabetes and CancerDiabetes Care, 2010
- Obesity prevalence from a European perspective: a systematic reviewBMC Public Health, 2008
- Carcinoembryonic Antigen and CD44 Variant Isoforms Cooperate to Mediate Colon Carcinoma Cell Adhesion to E- and L-selectin in Shear FlowJournal of Biological Chemistry, 2008
- Establishment of Reference Intervals of Tumor Markers in Korean AdultsAnnals of Laboratory Medicine, 2008
- The Metabolic SyndromeThe American Journal of Pathology, 2006
- Elevated serum CA19-9 levels in poorly controlled diabetic patients.Japanese Journal of Medicine, 1986
- Cumulative effects of age and pathology on plasma carcinoembryonic antigen in an unselected elderly populationEuropean Journal of Cancer and Clinical Oncology, 1984
- Carcinoembryonic antigen (CEA).Gut, 1972